| Year |
Citation |
Score |
| 2021 |
Schwarzschild MA, Ascherio A, Casaceli C, Curhan GC, Fitzgerald R, Kamp C, Lungu C, Macklin EA, Marek K, Mozaffarian D, Oakes D, Rudolph A, Shoulson I, Videnovic A, ... ... Litvan I, et al. Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial. Jama. 326: 926-939. PMID 34519802 DOI: 10.1001/jama.2021.10207 |
0.309 |
|
| 2021 |
Pilotto A, Romagnolo A, Scalvini A, Masellis M, Shimo Y, Bonanni L, Camicioli R, Wang LL, Dwivedi AK, Longardner K, Rodriguez-Porcel F, DiFrancesco M, Vizcarra JA, Montanaro E, Maule S, ... ... Litvan I, et al. Association of Orthostatic Hypotension With Cerebral Atrophy in Patients With Lewy Body Disorders. Neurology. PMID 34099524 DOI: 10.1212/WNL.0000000000012342 |
0.317 |
|
| 2021 |
Eglit GML, Lopez F, Schiehser DM, Pirogovsky-Turk E, Litvan I, Lessig S, Filoteo JV. Delineation of Apathy Subgroups in Parkinson's Disease: Differences in Clinical Presentation, Functional Ability, Health-related Quality of Life, and Caregiver Burden. Movement Disorders Clinical Practice. 8: 92-99. PMID 33426163 DOI: 10.1002/mdc3.13127 |
0.305 |
|
| 2020 |
Wu M, Ceponiene R, Bayram E, Litvan I. Two Patients with Niemann Pick Disease Type C Diagnosed in the Seventh Decade of Life. Movement Disorders Clinical Practice. 7: 961-964. PMID 33163568 DOI: 10.1002/Mdc3.13085 |
0.363 |
|
| 2020 |
Mills KA, Schneider RB, Saint-Hilaire M, Ross GW, Hauser RA, Lang AE, Halverson MJ, Oakes D, Eberly S, Litvan I, Blindauer K, Aquino C, Simuni T, Marras C. Cognitive impairment in Parkinson's disease: Associations between subjective and objective cognitive decline in a large longitudinal study. Parkinsonism & Related Disorders. 80: 127-132. PMID 32987359 DOI: 10.1016/j.parkreldis.2020.09.028 |
0.304 |
|
| 2020 |
Longardner K, Bayram E, Litvan I. Orthostatic Hypotension Is Associated With Cognitive Decline in Parkinson Disease Frontiers in Neurology. 11. PMID 32982926 DOI: 10.3389/Fneur.2020.00897 |
0.4 |
|
| 2020 |
Gasca-Salas C, Duff-Canning S, Armstrong MJ, Eslinger PJ, Schneider RB, Kennedy N, Chou KL, Persad C, Litvan I, Weintraub S, Marras C. Parkinson disease with mild cognitive impairment: domain-specific cognitive complaints predict dementia. Acta Neurologica Scandinavica. PMID 32740919 DOI: 10.1111/Ane.13326 |
0.375 |
|
| 2020 |
Rezvanian S, Litvan I, Standaert D, Jankovic J, Reich SG, Hall D, Shprecher DR, Bordelon Y, Dubinsky R, Kluger B. Understanding the relationship between freezing of gait and other progressive supranuclear palsy features. Parkinsonism & Related Disorders. 78: 56-60. PMID 32731191 DOI: 10.1016/J.Parkreldis.2020.07.009 |
0.326 |
|
| 2020 |
Sakae N, Santos OA, Pedraza O, Litvan I, Murray ME, Duara R, Uitti RJ, Wszolek ZK, Graff-Radford NR, Josephs KA, Dickson DW. Clinical and pathologic features of cognitive-predominant corticobasal degeneration. Neurology. PMID 32518146 DOI: 10.1212/Wnl.0000000000009734 |
0.372 |
|
| 2020 |
Coughlin DG, Litvan I. Progressive supranuclear palsy: Advances in diagnosis and management Parkinsonism & Related Disorders. 73: 105-116. PMID 32487421 DOI: 10.1016/J.Parkreldis.2020.04.014 |
0.35 |
|
| 2020 |
Toller G, Ranasinghe K, Cobigo Y, Staffaroni A, Appleby B, Brushaber D, Coppola G, Dickerson B, Domoto-Reilly K, Fields J, Fong J, Forsberg L, Ghoshal N, Graff-Radford N, Grossman M, ... ... Litvan I, et al. Revised Self-Monitoring Scale: A potential endpoint for frontotemporal dementia clinical trials. Neurology. PMID 32371446 DOI: 10.1212/Wnl.0000000000009451 |
0.306 |
|
| 2020 |
Lindestam Arlehamn CS, Dhanwani R, Pham J, Kuan R, Frazier A, Rezende Dutra J, Phillips E, Mallal S, Roederer M, Marder KS, Amara AW, Standaert DG, Goldman JG, Litvan I, Peters B, et al. α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson's disease. Nature Communications. 11: 1875. PMID 32313102 DOI: 10.1038/S41467-020-15626-W |
0.354 |
|
| 2020 |
Weintraub D, Caspell-Garcia C, Simuni T, Cho HR, Coffey CS, Aarsland D, Alcalay RN, Barrett MJ, Chahine LM, Eberling J, Espay AJ, Hamilton J, Hawkins KA, Leverenz J, Litvan I, et al. Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson disease. Annals of Clinical and Translational Neurology. PMID 32285645 DOI: 10.1002/Acn3.51022 |
0.386 |
|
| 2020 |
Bayram E, Dickson DW, Reich SG, Litvan I. Pathology-Proven Corticobasal Degeneration Presenting as Richardson's Syndrome Movement Disorders Clinical Practice. 7: 267-272. PMID 32258223 DOI: 10.1002/Mdc3.12900 |
0.375 |
|
| 2020 |
Staffaroni AM, Bajorek L, Casaletto KB, Cobigo Y, Goh SM, Wolf A, Heuer HW, Elahi FM, Ljubenkov PA, Dever R, Kornak J, Appleby B, Bove J, Bordelon Y, Brannelly P, ... ... Litvan I, et al. Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 16: 11-21. PMID 31914230 DOI: 10.1016/J.Jalz.2019.01.012 |
0.369 |
|
| 2019 |
Mishra VR, Sreenivasan KR, Yang Z, Zhuang X, Cordes D, Mari Z, Litvan I, Fernandez HH, Eidelberg D, Ritter A, Cummings JL, Walsh RR. Unique white matter structural connectivity in early-stage, drug-naive Parkinson disease. Neurology. PMID 31882528 DOI: 10.1212/Wnl.0000000000008867 |
0.346 |
|
| 2019 |
Harrington DL, Shen Q, Vincent Filoteo J, Litvan I, Huang M, Castillo GN, Lee RR, Bayram E. Abnormal distraction and load-specific connectivity during working memory in cognitively normal Parkinson's disease. Human Brain Mapping. PMID 31737972 DOI: 10.1002/Hbm.24868 |
0.321 |
|
| 2019 |
Shoeibi A, Olfati N, Litvan I. Frontrunner in Translation: Progressive Supranuclear Palsy. Frontiers in Neurology. 10: 1125. PMID 31695675 DOI: 10.3389/Fneur.2019.01125 |
0.386 |
|
| 2019 |
Shoeibi A, Litvan I, Juncos JL, Bordelon Y, Riley D, Standaert D, Reich SG, Shprecher D, Hall D, Marras C, Kluger B, Olfati N, Jankovic J. Are the International Parkinson disease and Movement Disorder Society progressive supranuclear palsy (IPMDS-PSP) diagnostic criteria accurate enough to differentiate common PSP phenotypes? Parkinsonism & Related Disorders. 69: 34-39. PMID 31665686 DOI: 10.1016/J.Parkreldis.2019.10.012 |
0.371 |
|
| 2019 |
Sakae N, Josephs KA, Litvan I, Murray ME, Duara R, Uitti RJ, Wszolek ZK, Graff-Radford NR, Dickson DW. Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 31433871 DOI: 10.1002/Mds.27816 |
0.416 |
|
| 2019 |
Sakae N, Josephs KA, Litvan I, Murray ME, Duara R, Uitti RJ, Wszolek ZK, van Gerpen J, Graff-Radford NR, Dickson DW. Clinicopathologic subtype of Alzheimer's disease presenting as corticobasal syndrome. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31399334 DOI: 10.1016/J.Jalz.2019.04.011 |
0.368 |
|
| 2019 |
Burstyn I, LaCroix AZ, Litvan I, Wallace RB, Checkoway H. Occupation and Parkinson disease in the Women's Health Initiative Observational Study. American Journal of Industrial Medicine. PMID 31328814 DOI: 10.1002/Ajim.23022 |
0.334 |
|
| 2019 |
Faust-Socher A, Duff-Canning S, Grabovsky A, Armstrong MJ, Rothberg B, Eslinger PJ, Meaney CA, Schneider RB, Tang-Wai DF, Fox SH, Zadikoff C, Kennedy N, Chou KL, Persad C, Litvan I, et al. Responsiveness to Change of the Montreal Cognitive Assessment, Mini-Mental State Examination, and SCOPA-Cog in Non-Demented Patients with Parkinson's Disease. Dementia and Geriatric Cognitive Disorders. 1-11. PMID 31315127 DOI: 10.1159/000496454 |
0.402 |
|
| 2019 |
Shoeibi A, Litvan I, Tolosa E, Ser TD, Lee E. Progression of two Progressive Supranuclear Palsy phenotypes with comparable initial disability. Parkinsonism & Related Disorders. PMID 31307919 DOI: 10.1016/J.Parkreldis.2019.07.010 |
0.399 |
|
| 2019 |
Lopez FV, Eglit GML, Schiehser DM, Pirogovsky-Turk E, Litvan I, Lessig S, Filoteo JV. Factor Analysis of the Apathy Scale in Parkinson's Disease. Movement Disorders Clinical Practice. 6: 379-386. PMID 31286007 DOI: 10.1002/Mdc3.12767 |
0.405 |
|
| 2019 |
Staffaroni AM, Cobigo Y, Goh SM, Kornak J, Bajorek L, Chiang K, Appleby B, Bove J, Bordelon Y, Brannelly P, Brushaber D, Caso C, Coppola G, Dever R, Dheel C, ... ... Litvan I, et al. Individualized atrophy scores predict dementia onset in familial frontotemporal lobar degeneration. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31272932 DOI: 10.1016/J.Jalz.2019.04.007 |
0.305 |
|
| 2019 |
Hicks A, Phillips K, Siwik C, Salmon P, Litvan I, Jablonski ME, Filoteo JV, Kayser K, Sephton SE. The role of dispositional mindfulness in a stress-health pathway among Parkinson's disease patients and caregiving partners. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. PMID 31201728 DOI: 10.1007/S11136-019-02217-6 |
0.364 |
|
| 2019 |
Boxer AL, Qureshi I, Ahlijanian M, Grundman M, Golbe LI, Litvan I, Honig LS, Tuite P, McFarland NR, O'Suilleabhain P, Xie T, Tirucherai GS, Bechtold C, Bordelon Y, Geldmacher DS, et al. Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trial. The Lancet. Neurology. 18: 549-558. PMID 31122495 DOI: 10.1016/S1474-4422(19)30139-5 |
0.31 |
|
| 2019 |
Grimm MJ, Respondek G, Stamelou M, Arzberger T, Ferguson L, Gelpi E, Giese A, Grossman M, Irwin DJ, Pantelyat A, Rajput A, Roeber S, van Swieten JC, Troakes C, Antonini A, ... ... Litvan I, et al. How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsy. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 30884545 DOI: 10.1002/Mds.27666 |
0.324 |
|
| 2019 |
Peterson B, Armstrong M, Galasko D, Galvin JE, Goldman J, Irwin D, Paulson H, Kaufer D, Leverenz J, Lunde A, McKeith IG, Siderowf A, Taylor A, Amodeo K, Barrett M, ... ... Litvan I, et al. Lewy Body Dementia Association's Research Centers of Excellence Program: Inaugural Meeting Proceedings. Alzheimer's Research & Therapy. 11: 23. PMID 30867052 DOI: 10.1186/S13195-019-0476-1 |
0.356 |
|
| 2019 |
Espay AJ, Vizcarra JA, Marsili L, Lang AE, Simon DK, Merola A, Josephs KA, Fasano A, Morgante F, Savica R, Greenamyre JT, Cambi F, Yamasaki TR, Tanner CM, Gan-Or Z, ... Litvan I, et al. Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases. Neurology. 92: 329-337. PMID 30745444 DOI: 10.1212/Wnl.0000000000006926 |
0.363 |
|
| 2019 |
Gillard DM, Proudfoot JA, Simões RM, Litvan I. End of life planning in parkinsonian diseases. Parkinsonism & Related Disorders. PMID 30718221 DOI: 10.1016/J.Parkreldis.2019.01.026 |
0.362 |
|
| 2019 |
Hoogland J, Boel JA, de Bie RMA, Schmand BA, Geskus RB, Dalrymple-Alford JC, Marras C, Adler CH, Weintraub D, Junque C, Pedersen KF, Mollenhauer B, Goldman JG, Tröster AI, Burn DJ, ... Litvan I, et al. Risk of Parkinson's disease dementia related to level I MDS PD-MCI. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 30653248 DOI: 10.1002/Mds.27617 |
0.422 |
|
| 2019 |
Bluett B, Bayram E, Litvan I. The virtual reality of Parkinson's disease freezing of gait: A systematic review. Parkinsonism & Related Disorders. 61: 26-33. PMID 30470656 DOI: 10.1016/J.Parkreldis.2018.11.013 |
0.391 |
|
| 2019 |
Olfati N, Shoeibi A, Litvan I. Progress in the treatment of Parkinson-Plus syndromes. Parkinsonism & Related Disorders. 59: 101-110. PMID 30314846 DOI: 10.1016/J.Parkreldis.2018.10.006 |
0.403 |
|
| 2019 |
Nakhla M, Filoteo J, Pluim C, Cabrera Tuazon A, Whiteley N, Zlatar Z, Lessig S, Litvan I, Schiehser D. B-18 Executive Functioning Best Predicts Performance-Based Financial Skills in Non-Demented Parkinson’s Disease Archives of Clinical Neuropsychology. 34: 963-963. DOI: 10.1093/Arclin/Acz034.101 |
0.375 |
|
| 2018 |
Soria JA, Huisa BN, Edland SD, Litvan I, Peavy GM, Salmon DP, Hansen LA, Galasko DR, Brewer JB, González HM, Rissman RA. Clinical-Neuropathological Correlations of Alzheimer's Disease and Related Dementias in Latino Volunteers. Journal of Alzheimer's Disease : Jad. PMID 30412501 DOI: 10.3233/Jad-180789 |
0.363 |
|
| 2018 |
Harrington DL, Shen Q, Theilmann RJ, Castillo GN, Litvan I, Filoteo JV, Huang M, Lee RR. Altered Functional Interactions of Inhibition Regions in Cognitively Normal Parkinson's Disease. Frontiers in Aging Neuroscience. 10: 331. PMID 30405399 DOI: 10.3389/Fnagi.2018.00331 |
0.358 |
|
| 2018 |
Shoeibi A, Litvan I. Prominent tongue and jaw tremor in a patient with probable Progressive Supranuclear Palsy. Movement Disorders Clinical Practice. 5: 99-100. PMID 30271811 DOI: 10.1002/Mdc3.12562 |
0.331 |
|
| 2018 |
Moreno GM, Gandhi R, Lessig SL, Wright B, Litvan I, Nahab FB. Mortality in patients with Parkinson disease psychosis receiving pimavanserin and quetiapine. Neurology. PMID 30258020 DOI: 10.1212/Wnl.0000000000006396 |
0.406 |
|
| 2018 |
Lopez FV, Split M, Filoteo JV, Litvan I, Moore RC, Pirogovsky-Turk E, Liu L, Lessig S, Schiehser DM. Does the Geriatric Depression Scale measure depression in Parkinson's disease? International Journal of Geriatric Psychiatry. PMID 30251374 DOI: 10.1002/Gps.4970 |
0.32 |
|
| 2018 |
Hoogland J, van Wanrooij LL, Boel JA, Goldman JG, Stebbins GT, Dalrymple-Alford JC, Marras C, Adler CH, Junque C, Pedersen KF, Mollenhauer B, Zabetian CP, Eslinger PJ, Lewis SJG, Wu RM, ... ... Litvan I, et al. Detecting Mild Cognitive Deficits in Parkinson's Disease: Comparison of Neuropsychological Tests. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 30216541 DOI: 10.1002/Mds.110 |
0.38 |
|
| 2018 |
Bluett B, Banks S, Cordes D, Bayram E, Mishra V, Cummings J, Litvan I. Neuroimaging and neuropsychological assessment of freezing of gait in Parkinson's disease. Alzheimer's & Dementia (New York, N. Y.). 4: 387-394. PMID 30211293 DOI: 10.1016/J.Trci.2018.04.010 |
0.428 |
|
| 2018 |
Berg D, Adler CH, Bloem BR, Chan P, Gasser T, Goetz CG, Halliday G, Lang AE, Lewis S, Li Y, Liepelt-Scarfone I, Litvan I, Marek K, Maetzler C, Mi T, et al. Movement disorder society criteria for clinically established early Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 30145841 DOI: 10.1002/Mds.27431 |
0.435 |
|
| 2018 |
Postuma RB, Poewe W, Litvan I, Lewis S, Lang AE, Halliday G, Goetz CG, Chan P, Slow E, Seppi K, Schaffer E, Rios-Romenets S, Mi T, Maetzler C, Li Y, et al. Validation of the MDS clinical diagnostic criteria for Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 30145797 DOI: 10.1002/Mds.27362 |
0.401 |
|
| 2018 |
Chahine LM, Urbe L, Caspell-Garcia C, Aarsland D, Alcalay R, Barone P, Burn D, Espay AJ, Hamilton JL, Hawkins KA, Lasch S, Leverenz JB, Litvan I, Richard I, Siderowf A, et al. Cognition among individuals along a spectrum of increased risk for Parkinson's disease. Plos One. 13: e0201964. PMID 30125297 DOI: 10.1371/Journal.Pone.0201964 |
0.409 |
|
| 2018 |
Iddi S, Li D, Aisen PS, Rafii MS, Litvan I, Thompson WK, Donohue MC. Estimating the Evolution of Disease in the Parkinson's Progression Markers Initiative. Neuro-Degenerative Diseases. 18: 173-190. PMID 30089306 DOI: 10.1159/000488780 |
0.399 |
|
| 2018 |
Koga S, Kouri N, Walton RL, Ebbert MTW, Josephs KA, Litvan I, Graff-Radford N, Ahlskog JE, Uitti RJ, van Gerpen JA, Boeve BF, Parks A, Ross OA, Dickson DW. Corticobasal degeneration with TDP-43 pathology presenting with progressive supranuclear palsy syndrome: a distinct clinicopathologic subtype. Acta Neuropathologica. PMID 29926172 DOI: 10.1007/S00401-018-1878-Z |
0.357 |
|
| 2018 |
Shoeibi A, Olfati N, Litvan I. Preclinical, phase I, and phase II investigational clinical trials for treatment of progressive supranuclear palsy Expert Opinion On Investigational Drugs. 27: 349-361. PMID 29602288 DOI: 10.1080/13543784.2018.1460356 |
0.379 |
|
| 2018 |
Litvan I, Kieburtz K, Tröster AI, Aarsland D. Strengths and challenges in conducting clinical trials in Parkinson's disease mild cognitive impairment. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 29573469 DOI: 10.1002/Mds.27345 |
0.425 |
|
| 2018 |
Goldman JG, Holden SK, Litvan I, McKeith I, Stebbins GT, Taylor JP. Evolution of diagnostic criteria and assessments for Parkinson's disease mild cognitive impairment. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 29488270 DOI: 10.1002/Mds.27323 |
0.442 |
|
| 2018 |
Weintraub D, Hamilton JL, Eberling J, Litvan I. At a crossroads: Revisiting mild cognitive impairment in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 29418018 DOI: 10.1002/Mds.27310 |
0.386 |
|
| 2017 |
Gerstenecker A, Roberson ED, Schellenberg GD, Standaert DG, Shprecher DR, Kluger BM, Litvan I. Genetic influences on cognition in progressive supranuclear palsy. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 29076559 DOI: 10.1002/Mds.27196 |
0.327 |
|
| 2017 |
Schonhaut DR, McMillan CT, Spina S, Dickerson BC, Siderowf A, Devous MD, Tsai R, Winer J, Russell DS, Litvan I, Roberson ED, Seeley WW, Grinberg LT, Kramer JH, Miller BL, et al. (18) F-flortaucipir tau PET distinguishes established progressive supranuclear palsy from controls and Parkinson's disease: A multicenter study. Annals of Neurology. PMID 28980714 DOI: 10.1002/Ana.25060 |
0.35 |
|
| 2017 |
Harrington DL, Shen Q, Castillo GN, Filoteo JV, Litvan I, Takahashi C, French C. Aberrant Intrinsic Activity and Connectivity in Cognitively Normal Parkinson's Disease. Frontiers in Aging Neuroscience. 9: 197. PMID 28674492 DOI: 10.3389/Fnagi.2017.00197 |
0.405 |
|
| 2017 |
Boxer AL, Yu JT, Golbe LI, Litvan I, Lang AE, Höglinger GU. Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches. The Lancet. Neurology. 16: 552-563. PMID 28653647 DOI: 10.1016/S1474-4422(17)30157-6 |
0.426 |
|
| 2017 |
Hoogland J, Boel JA, de Bie RMA, Geskus RB, Schmand BA, Dalrymple-Alford JC, Marras C, Adler CH, Goldman JG, Tröster AI, Burn DJ, Litvan I, Geurtsen GJ. Mild cognitive impairment as a risk factor for Parkinson's disease dementia. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 28605056 DOI: 10.1002/Mds.27002 |
0.423 |
|
| 2017 |
Caspell-Garcia C, Simuni T, Tosun-Turgut D, Wu IW, Zhang Y, Nalls M, Singleton A, Shaw LA, Kang JH, Trojanowski JQ, Siderowf A, Coffey C, Lasch S, Aarsland D, Burn D, ... ... Litvan I, et al. Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease. Plos One. 12: e0175674. PMID 28520803 DOI: 10.1371/Journal.Pone.0175674 |
0.434 |
|
| 2017 |
Respondek G, Kurz C, Arzberger T, Compta Y, Englund E, Ferguson LW, Gelpi E, Giese A, Irwin DJ, Meissner WG, Nilsson C, Pantelyat A, Rajput A, van Swieten JC, Troakes C, ... ... Litvan I, et al. Which ante mortem clinical features predict progressive supranuclear palsy pathology? Movement Disorders : Official Journal of the Movement Disorder Society. PMID 28500752 DOI: 10.1002/Mds.27034 |
0.378 |
|
| 2017 |
Whitwell JL, Höglinger GU, Antonini A, Bordelon Y, Boxer AL, Colosimo C, van Eimeren T, Golbe LI, Kassubek J, Kurz C, Litvan I, Pantelyat A, Rabinovici G, Respondek G, Rominger A, et al. Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be? Movement Disorders : Official Journal of the Movement Disorder Society. PMID 28500751 DOI: 10.1002/Mds.27038 |
0.342 |
|
| 2017 |
Höglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, Mollenhauer B, Müller U, Nilsson C, Whitwell JL, Arzberger T, Englund E, Gelpi E, Giese A, Irwin DJ, ... ... Litvan I, et al. Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 28467028 DOI: 10.1002/Mds.26987 |
0.365 |
|
| 2017 |
Holiday KA, Pirogovsky-Turk E, Malcarne VL, Filoteo JV, Litvan I, Lessig SL, Song D, Schiehser DM. Psychometric Properties and Characteristics of the North-East Visual Hallucinations Interview in Parkinson's Disease. Movement Disorders Clinical Practice. 1. PMID 28435846 DOI: 10.1002/Mdc3.12479 |
0.368 |
|
| 2017 |
Shoeibi A, Litvan I. Therapeutic options for Progressive Supranuclear Palsy including investigational drugs Expert Opinion On Orphan Drugs. 5: 575-587. DOI: 10.1080/21678707.2017.1335596 |
0.345 |
|
| 2017 |
Budur K, West T, Braunstein JB, Fogelman I, Bordelon YM, Litvan I, Roberson ED, Hu H, Verghese PB, Bateman RJ, Florian H, Wang D, Ryman D, Gault L, Goss S, et al. [O2-17-01]: RESULTS OF A PHASE 1, SINGLE ASCENDING DOSE, PLACEBO-CONTROLLED STUDY OF ABBV-8E12 IN PATIENTS WITH PROGRESSIVE SUPRANUCLEAR PALSY AND PHASE 2 STUDY DESIGN IN EARLY ALZHEIMER's DISEASE Alzheimer's & Dementia. 13: P599-P600. DOI: 10.1016/J.Jalz.2017.07.241 |
0.305 |
|
| 2017 |
Boxer AL, Rosen HJ, Boeve BF, Heuer H, Grossman M, Coppola G, Dickerson BC, Bordelon YM, Dheel C, Faber K, Fields JA, Fong J, Foroud TM, Ghoshal N, Graff-Radford N, ... ... Litvan I, et al. [P2-303]: ADVANCING RESEARCH AND TREATMENT IN FRONTOTEMPORAL LOBAR DEGENERATION (ARTFL) NORTH AMERICAN RARE DISEASE CLINICAL RESEARCH CONSORTIUM: PROGRESS AND CHARACTERIZATION OF INITIAL PARTICIPANTS Alzheimer's & Dementia. 13: P733-P734. DOI: 10.1016/J.Jalz.2017.06.956 |
0.318 |
|
| 2017 |
Phillips K, Salmon P, Siwik C, Rebholz W, Cash E, Litvan I, Filoteo J, Kayser K, Sephton S. A dyadic Mbsr intervention for Parkinson’s disease patients/caregivers: Effects on distress, cortisol, and inflammation Brain, Behavior, and Immunity. 66: e19-e20. DOI: 10.1016/J.Bbi.2017.07.078 |
0.366 |
|
| 2016 |
Bluett B, Litvan I, Cheng S, Juncos J, Riley DE, Standaert DG, Reich SG, Hall DA, Kluger B, Shprecher D, Marras C, Jankovic J. Understanding falls in progressive supranuclear palsy. Parkinsonism & Related Disorders. PMID 28007518 DOI: 10.1016/J.Parkreldis.2016.12.009 |
0.333 |
|
| 2016 |
Pirogovsky-Turk E, Moore RC, Filoteo JV, Litvan I, Song DD, Lessig SL, Schiehser DM. Neuropsychiatric Predictors of Cognitive Decline in Parkinson Disease: A Longitudinal Study. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. PMID 27838315 DOI: 10.1016/J.Jagp.2016.10.004 |
0.394 |
|
| 2016 |
Dutt S, Binney RJ, Heuer HW, Luong P, Attygalle S, Bhatt P, Marx GA, Elofson J, Tartaglia MC, Litvan I, McGinnis SM, Dickerson BC, Kornak J, Waltzman D, Voltarelli L, et al. Progression of brain atrophy in PSP and CBS over 6 months and 1 year. Neurology. PMID 27742814 DOI: 10.1212/Wnl.0000000000003305 |
0.357 |
|
| 2016 |
Nandipati S, Litvan I. Environmental Exposures and Parkinson’s Disease International Journal of Environmental Research and Public Health. 13: 881-881. PMID 27598189 DOI: 10.3390/Ijerph13090881 |
0.342 |
|
| 2016 |
Postuma RB, Berg D, Adler CH, Bloem BR, Chan P, Deuschl G, Gasser T, Goetz CG, Halliday G, Joseph L, Lang AE, Liepelt-Scarfone I, Litvan I, Marek K, Oertel W, et al. The new definition and diagnostic criteria of Parkinson's disease. The Lancet. Neurology. 15: 546-8. PMID 27302120 DOI: 10.1016/S1474-4422(16)00116-2 |
0.384 |
|
| 2016 |
Schiehser DM, Filoteo JV, Litvan I, Pirogovsky-Turk E, Lessig SL, Song DS. Cognitive functioning in individuals with Parkinson's disease and traumatic brain injury: A longitudinal study. Parkinsonism & Related Disorders. PMID 27260791 DOI: 10.1016/J.Parkreldis.2016.05.024 |
0.366 |
|
| 2016 |
Espay AJ, Bonato P, Nahab FB, Maetzler W, Dean JM, Klucken J, Eskofier BM, Merola A, Horak F, Lang AE, Reilmann R, Giuffrida J, Nieuwboer A, Horne M, Little MA, ... Litvan I, et al. Technology in Parkinson's disease: Challenges and opportunities. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 27125836 DOI: 10.1002/Mds.26642 |
0.398 |
|
| 2016 |
Guella I, Evans DM, Szu-Tu C, Nosova E, Bortnick SF, Goldman JG, Dalrymple-Alford J, Geurtsen GJ, Litvan I, Ross OA, Middleton LT, Parkkinen L, Farrer MJ. α-synuclein genetic variability: A biomarker for dementia in Parkinson's disease. Annals of Neurology. PMID 27091628 DOI: 10.1002/Ana.24664 |
0.461 |
|
| 2016 |
Besser LM, Litvan I, Monsell SE, Mock C, Weintraub S, Zhou XH, Kukull W. Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease. Parkinsonism & Related Disorders. PMID 27089852 DOI: 10.1016/J.Parkreldis.2016.04.007 |
0.426 |
|
| 2016 |
Brody DM, Litvan I, Warner S, Riley DE, Hall DA, Kluger BM, Shprecher DR, Cunningham CR. Relationship between uric acid levels and progressive supranuclear palsy. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 26890571 DOI: 10.1002/Mds.26535 |
0.313 |
|
| 2016 |
Split M, Lopez F, Schiehser D, Turk E, Lessig S, Song D, Litvan I, Filoteo J. C-64Differential Predictors of Burden and Depression Symptoms in Caregivers of Patients with Parkinson's Disease Archives of Clinical Neuropsychology. 31: 664.1-664. DOI: 10.1093/Arclin/Acw043.213 |
0.33 |
|
| 2016 |
Nguyen L, Pluim C, Schiehser D, Turk E, Lessig S, Song D, Litvan I, Filoteo J. C-61Predictors of Freezing of Gait in Parkinson's Disease: The Influence of Mood and Cognition Archives of Clinical Neuropsychology. 31: 663.1-663. DOI: 10.1093/Arclin/Acw043.210 |
0.307 |
|
| 2016 |
Ceponiene R, Edland SD, Reid TN, Rizaiza AA, Litvan I. Neuropsychiatric symptoms and their impact on quality of life in multiple system atrophy Cogent Psychology. 3: 1131476. DOI: 10.1080/23311908.2015.1131476 |
0.325 |
|
| 2015 |
Arena JE, Weigand SD, Whitwell JL, Hassan A, Eggers SD, Höglinger GU, Litvan I, Josephs KA. Progressive supranuclear palsy: progression and survival. Journal of Neurology. PMID 26705121 DOI: 10.1007/S00415-015-7990-2 |
0.374 |
|
| 2015 |
McKee AC, Cairns NJ, Dickson DW, Folkerth RD, Dirk Keene C, Litvan I, Perl DP, Stein TD, Vonsattel JP, Stewart W, Tripodis Y, Crary JF, Bieniek KF, Dams-O'Connor K, Alvarez VE, et al. The first NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy. Acta Neuropathologica. PMID 26667418 DOI: 10.1007/S00401-015-1515-Z |
0.359 |
|
| 2015 |
Pirogovsky-Turk E, Filoteo JV, Litvan I, Harrington DL. Structural MRI Correlates of Episodic Memory Processes in Parkinson's Disease Without Mild Cognitive Impairment. Journal of Parkinson's Disease. PMID 26577652 DOI: 10.3233/Jpd-150652 |
0.372 |
|
| 2015 |
Berg D, Postuma RB, Adler CH, Bloem BR, Chan P, Dubois B, Gasser T, Goetz CG, Halliday G, Joseph L, Lang AE, Liepelt-Scarfone I, Litvan I, Marek K, Obeso J, et al. MDS research criteria for prodromal Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 1600-11. PMID 26474317 DOI: 10.1002/Mds.26431 |
0.42 |
|
| 2015 |
Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, et al. MDS clinical diagnostic criteria for Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 1591-601. PMID 26474316 DOI: 10.1002/Mds.26424 |
0.413 |
|
| 2015 |
Mata IF, Jang Y, Kim CH, Hanna DS, Dorschner MO, Samii A, Agarwal P, Roberts JW, Klepitskaya O, Shprecher DR, Chung KA, Factor SA, Espay AJ, Revilla FJ, Higgins DS, ... Litvan I, et al. The RAB39B p.G192R mutation causes X-linked dominant Parkinson's disease. Molecular Neurodegeneration. 10: 50. PMID 26399558 DOI: 10.1186/S13024-015-0045-4 |
0.359 |
|
| 2015 |
Weintraub D, Simuni T, Caspell-Garcia C, Coffey C, Lasch S, Siderowf A, Aarsland D, Barone P, Burn D, Chahine LM, Eberling J, Espay AJ, Foster ED, Leverenz JB, Litvan I, et al. Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 919-27. PMID 25737166 DOI: 10.1002/Mds.26170 |
0.42 |
|
| 2015 |
Bluett B, Litvan I. Pathophysiology, genetics, clinical features, diagnosis and therapeutic trials in progressive supranuclear palsy Expert Opinion On Orphan Drugs. 3: 253-265. DOI: 10.1517/21678707.2015.1018180 |
0.412 |
|
| 2015 |
Grunho M, Sonies B, Frattali CM, Litvan I. Swallowing disturbances in the corticobasal syndrome Parkinsonism and Related Disorders. 21: 1342-1348. DOI: 10.1016/J.Parkreldis.2015.09.043 |
0.318 |
|
| 2014 |
Gatto E, Rodríguez-Violante M, Cosentino C, Chana-Cuevas P, Miranda M, Gallin E, Etcheverry JL, Nuñez Y, Parisi V, Persi G, Vecchi C, Sanguinetti A, Alleva A, Aparcana J, Torres L, ... Litvan I, et al. Pan-American Consortium of Multiple System Atrophy (PANMSA). A Pan-American multicentre cohort study of multiple system atrophy. Journal of Parkinson's Disease. 4: 693-8. PMID 25213997 DOI: 10.3233/Jpd-140434 |
0.361 |
|
| 2014 |
Boxer AL, Lang AE, Grossman M, Knopman DS, Miller BL, Schneider LS, Doody RS, Lees A, Golbe LI, Williams DR, Corvol JC, Ludolph A, Burn D, Lorenzl S, Litvan I, et al. Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial. The Lancet. Neurology. 13: 676-85. PMID 24873720 DOI: 10.1016/S1474-4422(14)70088-2 |
0.311 |
|
| 2014 |
Burn D, Weintraub D, Ravina B, Litvan I. Cognition in movement disorders: where can we hope to be in ten years? Movement Disorders : Official Journal of the Movement Disorder Society. 29: 704-11. PMID 24757118 DOI: 10.1002/Mds.25850 |
0.353 |
|
| 2014 |
Pirogovsky E, Schiehser DM, Litvan I, Obtera KM, Burke MM, Lessig SL, Song DD, Liu L, Filoteo JV. The utility of the Mattis Dementia Rating Scale in Parkinson's disease mild cognitive impairment. Parkinsonism & Related Disorders. 20: 627-31. PMID 24709086 DOI: 10.1016/J.Parkreldis.2014.03.010 |
0.427 |
|
| 2014 |
Beal MF, Oakes D, Shoulson I, Henchcliffe C, Galpern WR, Haas R, Juncos JL, Nutt JG, Voss TS, Ravina B, Shults CM, Helles K, Snively V, Lew MF, ... ... Litvan I, et al. A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit. Jama Neurology. 71: 543-52. PMID 24664227 DOI: 10.1001/Jamaneurol.2014.131 |
0.35 |
|
| 2014 |
Berg D, Postuma RB, Bloem B, Chan P, Dubois B, Gasser T, Goetz CG, Halliday GM, Hardy J, Lang AE, Litvan I, Marek K, Obeso J, Oertel W, Olanow CW, et al. Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 454-62. PMID 24619848 DOI: 10.1002/Mds.25844 |
0.41 |
|
| 2014 |
Litvan I, Kong M. Rate of decline in progressive supranuclear palsy. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 463-8. PMID 24615741 DOI: 10.1002/Mds.25843 |
0.357 |
|
| 2014 |
Monsell SE, Besser LM, Heller KB, Checkoway H, Litvan I, Kukull WA. Clinical and pathologic presentation in Parkinson's disease by apolipoprotein e4 allele status. Parkinsonism & Related Disorders. 20: 503-7. PMID 24582705 DOI: 10.1016/J.Parkreldis.2014.02.001 |
0.416 |
|
| 2014 |
Tolosa E, Litvan I, Höglinger GU, Burn D, Lees A, Andrés MV, Gómez-Carrillo B, León T, Del Ser T. A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 470-8. PMID 24532007 DOI: 10.1002/Mds.25824 |
0.358 |
|
| 2014 |
Pirogovsky E, Schiehser DM, Obtera KM, Burke MM, Lessig SL, Song DD, Litvan I, Filoteo JV. Instrumental activities of daily living are impaired in Parkinson's disease patients with mild cognitive impairment. Neuropsychology. 28: 229-37. PMID 24417192 DOI: 10.1037/Neu0000045 |
0.413 |
|
| 2014 |
Geurtsen GJ, Hoogland J, Goldman JG, Schmand BA, Tröster AI, Burn DJ, Litvan I. Parkinson's disease mild cognitive impairment: application and validation of the criteria. Journal of Parkinson's Disease. 4: 131-7. PMID 24296865 DOI: 10.3233/Jpd-130304 |
0.423 |
|
| 2014 |
Filoteo JV, Reed JD, Litvan I, Harrington DL. Volumetric correlates of cognitive functioning in nondemented patients with Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 360-7. PMID 24038502 DOI: 10.1002/Mds.25633 |
0.378 |
|
| 2014 |
Besser LM, Monsell SE, Heller K, Litvan I, Kukull W. Mild Cognitive Impairment Among Parkinson'S Disease Subjects In The Uniform Data Set Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.05.1255 |
0.365 |
|
| 2013 |
Williams DR, Litvan I. Parkinsonian syndromes. Continuum (Minneapolis, Minn.). 19: 1189-212. PMID 24092286 DOI: 10.1212/01.CON.0000436152.24038.e0 |
0.314 |
|
| 2013 |
Pirogovsky E, Martinez-Hannon M, Schiehser DM, Lessig SL, Song DD, Litvan I, Filoteo JV. Predictors of performance-based measures of instrumental activities of daily living in nondemented patients with Parkinson's disease. Journal of Clinical and Experimental Neuropsychology. 35: 926-33. PMID 24074137 DOI: 10.1080/13803395.2013.838940 |
0.389 |
|
| 2013 |
Gerstenecker A, Duff K, Mast B, Litvan I. Behavioral abnormalities in progressive supranuclear palsy. Psychiatry Research. 210: 1205-10. PMID 24035530 DOI: 10.1016/J.Psychres.2013.08.045 |
0.402 |
|
| 2013 |
Reginold W, Duff-Canning S, Meaney C, Armstrong MJ, Fox S, Rothberg B, Zadikoff C, Kennedy N, Gill D, Eslinger P, Marshall F, Mapstone M, Chou KL, Persad C, Litvan I, et al. Impact of mild cognitive impairment on health-related quality of life in Parkinson's disease. Dementia and Geriatric Cognitive Disorders. 36: 67-75. PMID 23774742 DOI: 10.1159/000350032 |
0.362 |
|
| 2013 |
Theilmann RJ, Reed JD, Song DD, Huang MX, Lee RR, Litvan I, Harrington DL. White-matter changes correlate with cognitive functioning in Parkinson's disease. Frontiers in Neurology. 4: 37. PMID 23630517 DOI: 10.3389/Fneur.2013.00037 |
0.384 |
|
| 2013 |
Marras C, Armstrong MJ, Meaney CA, Fox S, Rothberg B, Reginold W, Tang-Wai DF, Gill D, Eslinger PJ, Zadikoff C, Kennedy N, Marshall FJ, Mapstone M, Chou KL, Persad C, ... Litvan I, et al. Measuring mild cognitive impairment in patients with Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 626-33. PMID 23520128 DOI: 10.1002/Mds.25426 |
0.432 |
|
| 2013 |
Armstrong MJ, Litvan I, Lang AE, Bak TH, Bhatia KP, Borroni B, Boxer AL, Dickson DW, Grossman M, Hallett M, Josephs KA, Kertesz A, Lee SE, Miller BL, Reich SG, et al. Criteria for the diagnosis of corticobasal degeneration. Neurology. 80: 496-503. PMID 23359374 DOI: 10.1212/Wnl.0B013E31827F0Fd1 |
0.398 |
|
| 2013 |
Duff K, Gerstenecker A, Litvan I. Functional impairment in progressive supranuclear palsy. Neurology. 80: 380-4. PMID 23303854 DOI: 10.1212/Wnl.0B013E31827F0859 |
0.316 |
|
| 2013 |
Gerstenecker A, Mast B, Duff K, Ferman TJ, Litvan I. Executive dysfunction is the primary cognitive impairment in progressive supranuclear palsy. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 28: 104-13. PMID 23127882 DOI: 10.1093/Arclin/Acs098 |
0.39 |
|
| 2013 |
Armstrong MJ, Duff-Canning S, Tang-Wai DF, Fox S, Zadikoff C, Kennedy N, Gill D, Eslinger PJ, Mapstone M, Chou KL, Persad C, Litvan I, Mast BT, Marras C. The meaning of a "hippo" response on the Montreal Cognitive Assessment in Parkinson's disease. Parkinsonism & Related Disorders. 19: 463-5. PMID 23036511 DOI: 10.1016/J.Parkreldis.2012.09.005 |
0.377 |
|
| 2013 |
Munhoz RP, Espay AJ, Morgante F, Li JY, Teive HA, Dunn E, Gallin E, Litvan I. Long-duration Parkinson's disease: role of lateralization of motor features. Parkinsonism & Related Disorders. 19: 77-80. PMID 22858180 DOI: 10.1016/J.Parkreldis.2012.07.008 |
0.398 |
|
| 2013 |
Monsell S, Bristow K, Besser L, Checkoway H, Litvan I, Kukull W. P4-096: APOE-ɛ4 and clinical progression in Parkinson's disease Alzheimer's & Dementia. 9: P738-P739. DOI: 10.1016/J.Jalz.2013.05.1485 |
0.398 |
|
| 2012 |
Armstrong MJ, Naglie G, Duff-Canning S, Meaney C, Gill D, Eslinger PJ, Zadikoff C, Mapstone M, Chou KL, Persad C, Litvan I, Mast BT, Fox S, Tang-Wai DF, Marras C. Roles of Education and IQ in Cognitive Reserve in Parkinson's Disease-Mild Cognitive Impairment. Dementia and Geriatric Cognitive Disorders Extra. 2: 343-52. PMID 22962558 DOI: 10.1159/000341782 |
0.382 |
|
| 2012 |
Reginold W, Armstrong MJ, Duff-Canning S, Lang A, Tang-Wai D, Fox S, Rothberg B, Zadikoff C, Kennedy N, Gill D, Eslinger P, Mapstone M, Chou K, Persad C, Litvan I, et al. The pill questionnaire in a nondemented Parkinson's disease population. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 1308-11. PMID 22865587 DOI: 10.1002/Mds.25124 |
0.384 |
|
| 2012 |
Wang Y, Shi M, Chung KA, Zabetian CP, Leverenz JB, Berg D, Srulijes K, Trojanowski JQ, Lee VM, Siderowf AD, Hurtig H, Litvan I, Schiess MC, Peskind ER, Masuda M, et al. Phosphorylated α-synuclein in Parkinson's disease. Science Translational Medicine. 4: 121ra20. PMID 22344688 DOI: 10.1126/Scitranslmed.3002566 |
0.39 |
|
| 2012 |
Litvan I, Goldman JG, Tröster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH, Aarsland D, Kulisevsky J, Rodriguez-Oroz MC, Burn DJ, Barker RA, et al. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 349-56. PMID 22275317 DOI: 10.1002/Mds.24893 |
0.462 |
|
| 2012 |
Ferrara JM, Adam OR, Kirwin SM, Houghton DJ, Shepherd C, Vinette KM, Litvan I. Brain-lung-thyroid disease: clinical features of a kindred with a novel thyroid transcription factor 1 mutation. Journal of Child Neurology. 27: 68-73. PMID 21813802 DOI: 10.1177/0883073811413584 |
0.346 |
|
| 2012 |
Gatto E, Chana P, Etcheverry JL, Gallin E, Miranda M, Parisi V, Sanguinetti A, Violante MR, Litvan I. Pan-American Consortium of Multiple System Atrophy. Preliminary Report (P06.079) Neurology. 78. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P06.079 |
0.382 |
|
| 2012 |
Litvan I, Goldman JG, Tröster AI, Schmand BA, Weintraub D. Reply: Mild cognitive impairment in de novo Parkinson's disease according to Movement Disorder guidelines Movement Disorders. 27: 1707. DOI: 10.1002/Mds.25119 |
0.397 |
|
| 2011 |
Silverberg NB, Ryan LM, Carrillo MC, Sperling R, Petersen RC, Posner HB, Snyder PJ, Hilsabeck R, Gallagher M, Raber J, Rizzo A, Possin K, King J, Kaye J, Ott BR, ... ... Litvan I, et al. Assessment of cognition in early dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: e60-e76. PMID 23559893 DOI: 10.1016/J.Jalz.2011.05.001 |
0.372 |
|
| 2011 |
Kouri N, Murray ME, Hassan A, Rademakers R, Uitti RJ, Boeve BF, Graff-Radford NR, Wszolek ZK, Litvan I, Josephs KA, Dickson DW. Neuropathological features of corticobasal degeneration presenting as corticobasal syndrome or Richardson syndrome. Brain : a Journal of Neurology. 134: 3264-75. PMID 21933807 DOI: 10.1093/Brain/Awr234 |
0.365 |
|
| 2011 |
Espay AJ, Litvan I. Parkinsonism and frontotemporal dementia: the clinical overlap. Journal of Molecular Neuroscience : Mn. 45: 343-9. PMID 21892619 DOI: 10.1007/S12031-011-9632-1 |
0.422 |
|
| 2011 |
Höglinger GU, Melhem NM, Dickson DW, Sleiman PM, Wang LS, Klei L, Rademakers R, de Silva R, Litvan I, Riley DE, van Swieten JC, Heutink P, Wszolek ZK, Uitti RJ, Vandrovcova J, et al. Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nature Genetics. 43: 699-705. PMID 21685912 DOI: 10.1038/Ng.859 |
0.33 |
|
| 2011 |
Litvan I, Aarsland D, Adler CH, Goldman JG, Kulisevsky J, Mollenhauer B, Rodriguez-Oroz MC, Tröster AI, Weintraub D. MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 1814-24. PMID 21661055 DOI: 10.1002/Mds.23823 |
0.403 |
|
| 2011 |
Wenning GK, Litvan I, Tolosa E. Milestones in atypical and secondary Parkinsonisms. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 1083-95. PMID 21626553 DOI: 10.1002/Mds.23713 |
0.459 |
|
| 2011 |
Espay AJ, Spina S, Houghton DJ, Murrell JR, de Courten-Myers GM, Ghetti B, Litvan I. Rapidly progressive atypical parkinsonism associated with frontotemporal lobar degeneration and motor neuron disease. Journal of Neurology, Neurosurgery, and Psychiatry. 82: 751-3. PMID 20587488 DOI: 10.1136/Jnnp.2009.201608 |
0.392 |
|
| 2011 |
Dickson DW, Hauw JJ, Agid Y, Litvan I. Progressive Supranuclear Palsy and Corticobasal Degeneration Neurodegeneration: the Molecular Pathology of Dementia and Movement Disorders: Second Edition. 135-155. DOI: 10.1002/9781444341256.Ch15 |
0.376 |
|
| 2010 |
Chou KL, Amick MM, Brandt J, Camicioli R, Frei K, Gitelman D, Goldman J, Growdon J, Hurtig HI, Levin B, Litvan I, Marsh L, Simuni T, Tröster AI, Uc EY, et al. A recommended scale for cognitive screening in clinical trials of Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 2501-7. PMID 20878991 DOI: 10.1002/Mds.23362 |
0.382 |
|
| 2010 |
Bickel S, Alvarez L, Macias R, Pavon N, Leon M, Fernandez C, Houghton DJ, Salazar S, RodrÃguez-Oroz MC, Juncos J, Guridi J, Delong M, Obeso JA, Litvan I. Cognitive and neuropsychiatric effects of subthalamotomy for Parkinson's disease. Parkinsonism & Related Disorders. 16: 535-9. PMID 20650671 DOI: 10.1016/J.Parkreldis.2010.06.008 |
0.397 |
|
| 2010 |
Gerstenecker A, Mast BT, Litvan I. Neuropsychiatric and cognitive disorders in other Parkinsonian disorders Neuropsychiatric and Cognitive Changes in Parkinson's Disease and Related Movement Disorders: Diagnosis and Management. 261-274. DOI: 10.1017/CBO9781139856669.023 |
0.331 |
|
| 2009 |
Dickson DW, Braak H, Duda JE, Duyckaerts C, Gasser T, Halliday GM, Hardy J, Leverenz JB, Del Tredici K, Wszolek ZK, Litvan I. Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria. The Lancet. Neurology. 8: 1150-7. PMID 19909913 DOI: 10.1016/S1474-4422(09)70238-8 |
0.442 |
|
| 2009 |
Rodriguez-Oroz MC, Jahanshahi M, Krack P, Litvan I, Macias R, Bezard E, Obeso JA. Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms. The Lancet. Neurology. 8: 1128-39. PMID 19909911 DOI: 10.1016/S1474-4422(09)70293-5 |
0.412 |
|
| 2009 |
Uc EY, McDermott MP, Marder KS, Anderson SW, Litvan I, Como PG, Auinger P, Chou KL, Growdon JC. Incidence of and risk factors for cognitive impairment in an early parkinson disease clinical trial cohort Neurology. 73: 1469-1477. PMID 19884574 DOI: 10.1212/Wnl.0B013E3181Bf992F |
0.414 |
|
| 2009 |
Ludolph AC, Kassubek J, Landwehrmeyer BG, Mandelkow E, Mandelkow EM, Burn DJ, Caparros-Lefebvre D, Frey KA, de Yebenes JG, Gasser T, Heutink P, Höglinger G, Jamrozik Z, Jellinger KA, Kazantsev A, ... ... Litvan I, et al. Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 16: 297-309. PMID 19364361 DOI: 10.1111/J.1468-1331.2008.02513.X |
0.435 |
|
| 2008 |
Latourelle JC, Sun M, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten GF, Watts RL, Guttman M, Racette BA, Perlmutter JS, Ahmed A, Shill HA, ... ... Litvan I, et al. The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study. Bmc Medicine. 6: 32. PMID 18986508 DOI: 10.1186/1741-7015-6-32 |
0.34 |
|
| 2008 |
McNicoll CF, Latourelle JC, MacDonald ME, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten GF, Watts RL, Guttman M, Racette BA, Perlmutter JS, Ahmed A, ... ... Litvan I, et al. Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: the GenePD study. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 1596-601. PMID 18649400 DOI: 10.1002/Mds.22186 |
0.383 |
|
| 2008 |
DeStefano AL, Latourelle J, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten GF, Watts R, Guttman M, Racette BA, Perlmutter JS, Marlor L, Shill HA, ... ... Litvan I, et al. Replication of association between ELAVL4 and Parkinson disease: the GenePD study. Human Genetics. 124: 95-9. PMID 18587682 DOI: 10.1007/S00439-008-0526-4 |
0.351 |
|
| 2008 |
Tobin JE, Latourelle JC, Lew MF, Klein C, Suchowersky O, Shill HA, Golbe LI, Mark MH, Growdon JH, Wooten GF, Racette BA, Perlmutter JS, Watts R, Guttman M, Baker KB, ... ... Litvan I, et al. Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study. Neurology. 71: 28-34. PMID 18509094 DOI: 10.1212/01.Wnl.0000304051.01650.23 |
0.363 |
|
| 2008 |
Chand P, Litvan I. Progressive supranuclear palsy and corticobasal degeneration: Similarities and differences Future Neurology. 3: 299-307. DOI: 10.2217/14796708.3.3.299 |
0.375 |
|
| 2007 |
Houghton DJ, Litvan I. Unraveling progressive supranuclear palsy: from the bedside back to the bench. Parkinsonism & Related Disorders. 13: S341-6. PMID 18267262 DOI: 10.1016/S1353-8020(08)70028-2 |
0.359 |
|
| 2007 |
Dubois B, Burn D, Goetz C, Aarsland D, Brown RG, Broe GA, Dickson D, Duyckaerts C, Cummings J, Gauthier S, Korczyn A, Lees A, Levy R, Litvan I, Mizuno Y, et al. Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 2314-24. PMID 18098298 DOI: 10.1002/Mds.21844 |
0.403 |
|
| 2007 |
Litvan I. Update of atypical Parkinsonian disorders. Current Opinion in Neurology. 20: 434-7. PMID 17620879 DOI: 10.1097/Wco.0B013E32823Ecfa7 |
0.323 |
|
| 2007 |
Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, ... Litvan I, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 1689-707; quiz 1837. PMID 17542011 DOI: 10.1002/Mds.21507 |
0.434 |
|
| 2007 |
Litvan I, Chesselet MF, Gasser T, Di Monte DA, Parker D, Hagg T, Hardy J, Jenner P, Myers RH, Price D, Hallett M, Langston WJ, Lang AE, Halliday G, Rocca W, et al. The etiopathogenesis of Parkinson disease and suggestions for future research. Part II. Journal of Neuropathology and Experimental Neurology. 66: 329-36. PMID 17483689 DOI: 10.1097/Nen.0B013E318053716A |
0.363 |
|
| 2006 |
Wilk JB, Tobin JE, Suchowersky O, Shill HA, Klein C, Wooten GF, Lew MF, Mark MH, Guttman M, Watts RL, Singer C, Growdon JH, Latourelle JC, Saint-Hilaire MH, DeStefano AL, ... ... Litvan I, et al. Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: the GenePD Study. Neurology. 67: 2206-10. PMID 17190945 DOI: 10.1212/01.Wnl.0000249149.22407.D1 |
0.326 |
|
| 2006 |
Chand P, Grafman J, Dickson D, Ishizawa K, Litvan I. Alzheimer's disease presenting as corticobasal syndrome. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 2018-22. PMID 16977625 DOI: 10.1002/Mds.21055 |
0.376 |
|
| 2006 |
Sun M, Latourelle JC, Wooten GF, Lew MF, Klein C, Shill HA, Golbe LI, Mark MH, Racette BA, Perlmutter JS, Parsian A, Guttman M, Nicholson G, Xu G, Wilk JB, ... ... Litvan I, et al. Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study. Archives of Neurology. 63: 826-32. PMID 16769863 DOI: 10.1001/Archneur.63.6.826 |
0.31 |
|
| 2006 |
van Balken I, Litvan I. Current and future treatments in progressive supranuclear palsy. Current Treatment Options in Neurology. 8: 211-23. PMID 16569380 DOI: 10.1007/S11940-006-0012-Z |
0.379 |
|
| 2006 |
Gröschel K, Kastrup A, Litvan I, Schulz JB. Penguins and hummingbirds: midbrain atrophy in progressive supranuclear palsy. Neurology. 66: 949-50. PMID 16567726 DOI: 10.1212/01.Wnl.0000203342.77115.Bf |
0.353 |
|
| 2006 |
Ross OA, Toft M, Whittle AJ, Johnson JL, Papapetropoulos S, Mash DC, Litvan I, Gordon MF, Wszolek ZK, Farrer MJ, Dickson DW. Lrrk2 and Lewy body disease. Annals of Neurology. 59: 388-93. PMID 16437559 DOI: 10.1002/Ana.20731 |
0.395 |
|
| 2005 |
Karamohamed S, Latourelle JC, Racette BA, Perlmutter JS, Wooten GF, Lew M, Klein C, Shill H, Golbe LI, Mark MH, Guttman M, Nicholson G, Wilk JB, Saint-Hilaire M, DeStefano AL, ... ... Litvan I, et al. BDNF genetic variants are associated with onset age of familial Parkinson disease: GenePD Study. Neurology. 65: 1823-5. PMID 16344533 DOI: 10.1212/01.Wnl.0000187075.81589.Fd |
0.357 |
|
| 2005 |
McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, ... ... Litvan I, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 65: 1863-72. PMID 16237129 DOI: 10.1212/01.Wnl.0000187889.17253.B1 |
0.42 |
|
| 2005 |
Magherini A, Litvan I. Cognitive and behavioral aspects of PSP since Steele, Richardson and Olszewski's description of PSP 40 years ago and Albert's delineation of the subcortical dementia 30 years ago Neurocase. 11: 250-262. PMID 16093225 DOI: 10.1080/13554790590962979 |
0.361 |
|
| 2005 |
Dubois B, Slachevsky A, Pillon B, Beato R, Villalponda JM, Litvan I. "Applause sign" helps to discriminate PSP from FTD and PD Neurology. 64: 2132-2133. PMID 15985587 DOI: 10.1212/01.Wnl.0000165977.38272.15 |
0.428 |
|
| 2005 |
Tsuboi Y, Josephs KA, Boeve BF, Litvan I, Caselli RJ, Caviness JN, Uitti RJ, Bott AD, Dickson DW. Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 982-8. PMID 15834857 DOI: 10.1002/Mds.20478 |
0.367 |
|
| 2005 |
Alvarez L, Macias R, Lopez G, Alvarez E, Pavon N, Rodriguez-Oroz MC, Juncos JL, Maragoto C, Guridi J, Litvan I, Tolosa ES, Koller W, Vitek J, DeLong MR, Obeso JA. Bilateral subthalamotomy in Parkinson's disease: initial and long-term response. Brain : a Journal of Neurology. 128: 570-83. PMID 15689366 DOI: 10.1093/Brain/Awh397 |
0.389 |
|
| 2005 |
Litvan I. Progressive Supranuclear Palsy Advances in Neurology. 80: 287-308. DOI: 10.1385/1-59259-834-X:287 |
0.455 |
|
| 2004 |
Litvan I. Update on progressive supranuclear palsy. Current Neurology and Neuroscience Reports. 4: 296-302. PMID 15217544 DOI: 10.1007/S11910-004-0055-Z |
0.323 |
|
| 2004 |
Gröschel K, Hauser TK, Luft A, Patronas N, Dichgans J, Litvan I, Schulz JB. Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration. Neuroimage. 21: 714-24. PMID 14980574 DOI: 10.1016/J.Neuroimage.2003.09.070 |
0.314 |
|
| 2004 |
Perry T, Litvan I. Diagnostic issues in non-AD dementias Clinical Neuroscience Research. 3: 363-374. DOI: 10.1016/J.Cnr.2004.04.003 |
0.372 |
|
| 2003 |
Litvan I. Update on epidemiological aspects of progressive supranuclear palsy. Movement Disorders : Official Journal of the Movement Disorder Society. 18: S43-50. PMID 14502655 DOI: 10.1002/Mds.10562 |
0.31 |
|
| 2003 |
Aarsland D, Litvan I, Salmon D, Galasko D, Wentzel-Larsen T, Larsen JP. Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: Comparison with progressive supranuclear palsy and Alzheimer's disease Journal of Neurology, Neurosurgery and Psychiatry. 74: 1215-1220. PMID 12933921 DOI: 10.1136/Jnnp.74.9.1215 |
0.433 |
|
| 2003 |
Boeve BF, Lang AE, Litvan I. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Annals of Neurology. 54: S15-9. PMID 12833363 DOI: 10.1002/Ana.10570 |
0.334 |
|
| 2003 |
Litvan I, Bhatia KP, Burn DJ, Goetz CG, Lang AE, McKeith I, Quinn N, Sethi KD, Shults C, Wenning GK. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Movement Disorders : Official Journal of the Movement Disorder Society. 18: 467-86. PMID 12722160 DOI: 10.1002/Mds.10459 |
0.386 |
|
| 2003 |
Goetz CG, Leurgans S, Lang AE, Litvan I. Progression of gait, speech and swallowing deficits in progressive supranuclear palsy. Neurology. 60: 917-22. PMID 12654953 DOI: 10.1212/01.Wnl.0000052686.97625.27 |
0.381 |
|
| 2003 |
Frattali C, Duffy JR, Litvan I, Patsalides AD, Grafman J. Yes/no reversals as neurobehavioral sequela: a disorder of language, praxis, or inhibitory control? European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 10: 103-6. PMID 12535005 DOI: 10.1046/J.1468-1331.2003.00545.X |
0.312 |
|
| 2002 |
Dickson DW, Bergeron C, Chin SS, Duyckaerts C, Horoupian D, Ikeda K, Jellinger K, Lantos PL, Lippa CF, Mirra SS, Tabaton M, Vonsattel JP, Wakabayashi K, Litvan I. Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. Journal of Neuropathology and Experimental Neurology. 61: 935-46. PMID 12430710 DOI: 10.1093/Jnen/61.11.935 |
0.345 |
|
| 2002 |
Müller J, Seppi K, Stefanova N, Poewe W, Litvan I, Wenning GK. Freezing of gait in postmortem-confirmed atypical parkinsonism. Movement Disorders : Official Journal of the Movement Disorder Society. 17: 1041-5. PMID 12360556 DOI: 10.1002/Mds.10234 |
0.407 |
|
| 2001 |
Jellinger KA, Paulus W, Wrocklage C, Litvan I. Effects of closed traumatic brain injury and genetic factors on the development of Alzheimer's disease. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 8: 707-10. PMID 11784357 DOI: 10.1046/J.1468-1331.2001.00322.X |
0.316 |
|
| 2001 |
Kulisevsky J, Litvan I, Berthier ML, Pascual-Sedano B, Paulsen JS, Cummings JL. Neuropsychiatric assessment of Gilles de la Tourette patients: comparative study with other hyperkinetic and hypokinetic movement disorders. Movement Disorders : Official Journal of the Movement Disorder Society. 16: 1098-104. PMID 11748741 DOI: 10.1002/Mds.1225 |
0.327 |
|
| 2001 |
Jellinger KA, Paulus W, Wrocklage C, Litvan I. Traumatic brain injury as a risk factor for Alzheimer disease. Comparison of two retrospective autopsy cohorts with evaluation of ApoE genotype. Bmc Neurology. 1: 3. PMID 11504565 DOI: 10.1186/1471-2377-1-3 |
0.304 |
|
| 2001 |
Litvan I, Phipps M, Pharr VL, Hallett M, Grafman J, Salazar A. Randomized placebo-controlled trial of donepezil in patients with progressive supranuclear palsy. Neurology. 57: 467-73. PMID 11502915 DOI: 10.1212/Wnl.57.3.467 |
0.339 |
|
| 2001 |
Houlden H, Baker M, Morris HR, MacDonald N, Pickering-Brown S, Adamson J, Lees AJ, Rossor MN, Quinn NP, Kertesz A, Khan MN, Hardy J, Lantos PL, St George-Hyslop P, Munoz DG, ... ... Litvan I, et al. Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology. 56: 1702-6. PMID 11425937 DOI: 10.1212/Wnl.56.12.1702 |
0.313 |
|
| 2001 |
Litvan I. Therapy and management of frontal lobe dementia patients Neurology. 56: S41-S45. PMID 11402150 DOI: 10.1212/Wnl.56.Suppl_4.S41 |
0.415 |
|
| 2001 |
Litvan I. Diagnosis and management of progressive supranuclear palsy Seminars in Neurology. 21: 41-48. PMID 11346024 DOI: 10.1055/S-2001-13118 |
0.339 |
|
| 2001 |
Sommer M, Grafman J, Litvan I, Hallett M. Impairment of eyeblink classical conditioning in progressive supranuclear palsy. Movement Disorders : Official Journal of the Movement Disorder Society. 16: 240-51. PMID 11295776 DOI: 10.1002/Mds.1050 |
0.34 |
|
| 2001 |
Pharr V, Uttl B, Stark M, Litvan I, Fantie B, Grafman J. Comparison of apraxia in corticobasal degeneration and progressive supranuclear palsy. Neurology. 56: 957-63. PMID 11294936 DOI: 10.1212/Wnl.56.7.957 |
0.393 |
|
| 2001 |
Aarsland D, Litvan I, Larsen JP. Neuropsychiatric symptoms of patients with progressive supranuclear palsy and parkinson's disease Journal of Neuropsychiatry and Clinical Neurosciences. 13: 42-49. PMID 11207328 DOI: 10.1176/Jnp.13.1.42 |
0.408 |
|
| 2001 |
Müller J, Wenning GK, Verny M, McKee A, Chaudhuri KR, Jellinger K, Poewe W, Litvan I. Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders Archives of Neurology. 58: 259-264. PMID 11176964 DOI: 10.1001/Archneur.58.2.259 |
0.444 |
|
| 2000 |
Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: A frontal assessment battery at bedside Neurology. 55: 1621-1626. PMID 11113214 DOI: 10.1212/Wnl.55.11.1621 |
0.354 |
|
| 2000 |
Müller J, Wenning GK, Jellinger K, McKee A, Poewe W, Litvan I. Progression of Hoehn and Yahr stages in parkinsonian disorders: A clinicopathologic study Neurology. 55: 888-891. PMID 10994019 DOI: 10.1212/Wnl.55.6.888 |
0.378 |
|
| 2000 |
Hallett M, Litvan I, Lenz F, Ahlskog E, Grossman R, Jankovic J, Narabayashi H, Tasker R, Lozano AM, Delong M, Lang AE, Obeso JA, Waters C, Koller WC, Benabid AL, et al. Scientific position paper of the movement disorder society evaluation of surgery for Parkinson's disease Movement Disorders. 15: 436-438. PMID 10830406 DOI: 10.1002/1531-8257(200005)15:3<436::Aid-Mds1003>3.0.Co;2-L |
0.331 |
|
| 2000 |
Rivaud-Péchoux S, Vidailhet M, Gallouedec G, Litvan I, Gaymard B, Pierrot-Deseilligny C. Longitudinal ocular motor study in corticobasal degeneration and progressive supranuclear palsy Neurology. 54: 1029-1032. PMID 10720270 DOI: 10.1212/Wnl.54.5.1029 |
0.352 |
|
| 1999 |
Hallett M, Litvan I. Evaluation of surgery for Parkinson's disease: A report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology Neurology. 53: 1910-1921. PMID 10599758 DOI: 10.1212/Wnl.53.9.1910 |
0.358 |
|
| 1999 |
Wenning GK, Ebersbach G, Verny M, Chaudhuri KR, Jellinger K, McKee A, Poewe W, Litvan I. Progression of falls in postmortem-confirmed parkinsonian disorders Movement Disorders. 14: 947-950. PMID 10584668 DOI: 10.1002/1531-8257(199911)14:6<947::Aid-Mds1006>3.0.Co;2-O |
0.425 |
|
| 1999 |
Litvan I. Recent advances in atypical parkinsonian disorders Current Opinion in Neurology. 12: 441-446. PMID 10555833 DOI: 10.1097/00019052-199908000-00011 |
0.339 |
|
| 1999 |
Litvan I, Caparros-Lefebvre D, Lees A, Collins MA, Steele JC, Morris HR, Lees AJ, Perez-Tur J, McGeer PL. Atypical parkinsonism in the French West Indies (multiple letters) [4] Lancet. 354: 1472-1474. PMID 10543694 DOI: 10.1016/S0140-6736(05)77611-X |
0.363 |
|
| 1999 |
Litvan I, Grimes DA, Lang AE, Jankovic J, McKee A, Verny M, Jellinger K, Chaudhuri KR, Pearce RK. Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration Journal of Neurology. 246: II1-5. PMID 10525996 DOI: 10.1007/Bf03161075 |
0.465 |
|
| 1999 |
Lopez OL, Litvan I, Catt KE, Stowe R, Klunk W, Kaufer DI, Becker JT, DeKosky ST. Accuracy of four clinical diagnostic criteria for the diagnosis of neurodegenerative dementias. Neurology. 53: 1292-9. PMID 10522887 DOI: 10.1212/Wnl.53.6.1292 |
0.364 |
|
| 1999 |
Wenning GK, Scherfler C, Granata R, Bösch S, Verny M, Chaudhuri KR, Jellinger K, Poewe W, Litvan I. Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: A clinicopathological study Journal of Neurology Neurosurgery and Psychiatry. 67: 620-623. PMID 10519868 DOI: 10.1136/Jnnp.67.5.620 |
0.428 |
|
| 1999 |
Frattali CM, Sonies BC, Chi-Fishman G, Litvan I. Effects of physostigmine on swallowing and oral motor functions in patients with progressive supranuclear palsy: A pilot study Dysphagia. 14: 165-168. PMID 10341115 DOI: 10.1007/Pl00009600 |
0.304 |
|
| 1999 |
Gilman S, Low PA, Quinn N, Albanese A, Ben-Shlomo Y, Fowler CJ, Kaufmann H, Klockgether T, Lang AE, Lantos PL, Litvan I, Mathias CJ, Oliver E, Robertson D, Schatz I, et al. Consensus statement on the diagnosis of multiple system atrophy. Journal of the Neurological Sciences. 163: 94-8. PMID 10223419 DOI: 10.1016/S0022-510X(98)00304-9 |
0.365 |
|
| 1999 |
Litvan I. Recent advances in Parkinson disease Revista De Neurologia. 29: 139-145. DOI: 10.33588/Rn.2902.98502 |
0.383 |
|
| 1999 |
Litvan I. 7th Symposium on the Treatment of Parkinson's Disease, Osaka, Japan, 3 October 1998: Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration Journal of Neurology, Supplement. 246: II1-II5. |
0.373 |
|
| 1998 |
Litvan I, Jankovic J, Goetz CG, Wenning GK, Sastry N, Jellinger K, McKee A, Lai EC, Brandel JP, Verny M, Ray-Chaudhuri K, Pearce RK, Bartko JJ, Agid Y. Accuracy of the clinical diagnosis of postencephalitic parkinsonism: a clinicopathologic study. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 5: 451-457. PMID 10210873 DOI: 10.1046/J.1468-1331.1998.550451.X |
0.378 |
|
| 1998 |
Litvan I, Hutton M. Clinical and genetic aspects of progressive supranuclear palsy. Journal of Geriatric Psychiatry and Neurology. 11: 107-14. PMID 9877531 DOI: 10.1177/089198879801100208 |
0.414 |
|
| 1998 |
Gilman S, Low P, Quinn N, Albanese A, Ben-Shlomo Y, Fowler C, Kaufmann H, Klockgether T, Lang A, Lantos P, Litvan I, Mathias C, Oliver E, Robertson D, Schatz I, et al. Consensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American Academy of Neurology. Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society. 8: 359-62. PMID 9869555 DOI: 10.1007/Bf02309628 |
0.363 |
|
| 1998 |
Litvan I. Parkinsonian features: When are they Parkinson disease? Journal of the American Medical Association. 280: 1654-1655. PMID 9831984 DOI: 10.1001/Jama.280.19.1654 |
0.376 |
|
| 1998 |
Uttl B, Santacruz P, Litvan I, Grafman J. Caregiving in progressive supranuclear palsy. Neurology. 51: 1303-9. PMID 9818850 DOI: 10.1212/Wnl.51.5.1303 |
0.326 |
|
| 1998 |
Litvan I, Cummings JL, Mega M. Neuropsychiatric features of corticobasal degeneration Journal of Neurology Neurosurgery and Psychiatry. 65: 717-721. PMID 9810944 DOI: 10.1136/Jnnp.65.5.717 |
0.328 |
|
| 1998 |
Litvan I, Paulsen JS, Mega MS, Cummings JL. Neuropsychiatric assessment of patients with hyperkinetic and hypokinetic movement disorders. Archives of Neurology. 55: 1313-9. PMID 9779658 DOI: 10.1001/Archneur.55.10.1313 |
0.306 |
|
| 1998 |
Litvan I. Progressive supranuclear palsy revisited Acta Neurologica Scandinavica. 98: 73-84. PMID 9724003 DOI: 10.1111/J.1600-0404.1998.Tb01723.X |
0.326 |
|
| 1998 |
Kompoliti K, Goetz CG, Litvan I, Jellinger K, Verny M. Pharmacological therapy in progressive supranuclear palsy Archives of Neurology. 55: 1099-1102. PMID 9708960 DOI: 10.1001/Archneur.55.8.1099 |
0.346 |
|
| 1998 |
Levy ML, Cummings JL, Fairbanks LA, Masterman D, Miller BL, Craig AH, Paulsen JS, Litvan I. Apathy is not depression Journal of Neuropsychiatry and Clinical Neurosciences. 10: 314-319. PMID 9706539 DOI: 10.1176/Jnp.10.3.314 |
0.333 |
|
| 1998 |
Litvan I, MacIntyre A, Goetz CG, Wenning GK, Jellinger K, Verny M, Bartko JJ, Jankovic J, McKee A, Brandel JP, Chaudhuri KR, Lai EC, D'Olhaberriague L, Pearce RK, Agid Y. Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study. Archives of Neurology. 55: 969-78. PMID 9678315 DOI: 10.1001/Archneur.55.7.969 |
0.406 |
|
| 1998 |
Litvan I, Booth V, Wenning GK, Bartko JJ, Goetz CG, McKee A, Jankovic J, Jellinger K, Lai EC, Brandel JP, Verny M, Chaudhuri KR, Pearce RK, Agid Y. Retrospective application of a set of clinical diagnostic criteria for the diagnosis of multiple system atrophy. Journal of Neural Transmission (Vienna, Austria : 1996). 105: 217-27. PMID 9660099 DOI: 10.1007/S007020050050 |
0.365 |
|
| 1998 |
Santacruz P, Uttl B, Litvan I, Grafman J. Progressive supranuclear palsy: a survey of the disease course. Neurology. 50: 1637-47. PMID 9633705 DOI: 10.1212/Wnl.50.6.1637 |
0.319 |
|
| 1998 |
Litvan I. Methodological and research issues in the evaluation of biological diagnostic markers for Alzheimer's disease Neurobiology of Aging. 19: 121-123. PMID 9558145 DOI: 10.1016/S0197-4580(98)00019-0 |
0.354 |
|
| 1998 |
Davies P, Resnick J, Resnick B, Gilman S, Growdon JH, Khachaturian ZS, Radebaugh TS, Roses AD, Selkoe DJ, Trojanowski JQ, Blass JP, Gibson GE, Sheu KFR, Blennow K, Delacourte A, ... ... Litvan I, et al. Consensus report of the working group on: 'Molecular and biochemical markers of Alzheimer's disease' Neurobiology of Aging. 19: 109-116. PMID 9558143 DOI: 10.1016/S0197-4580(98)00022-0 |
0.331 |
|
| 1998 |
Wenning GK, Litvan I, Jankovic J, Granata R, Mangone CA, McKee A, Poewe W, Jellinger K, Chaudhuri KR, D'Olhaberriague L, Pearce RKB. Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination Journal of Neurology Neurosurgery and Psychiatry. 64: 184-189. PMID 9489528 DOI: 10.1136/Jnnp.64.2.184 |
0.423 |
|
| 1998 |
Litvan I, McKee A, Jellinger K, Jankovic J, Wenning GK. What are the Obstacles for an Accurate Clinical Diagnosis of Pick's disease? Neurology. 50: 1193-1193. DOI: 10.1212/Wnl.50.4.1193 |
0.39 |
|
| 1998 |
Litvan I. Progressive supranuclear palsy: Staring into the past, moving into the future Neurologist. 4: 13-20. DOI: 10.1097/00127893-199801000-00003 |
0.319 |
|
| 1997 |
Wenning GK, Jellinger K, Litvan I. Supranuclear gaze palsy and eyelid apraxia in postencephalitic parkinsonism Journal of Neural Transmission. 104: 845-865. PMID 9451717 DOI: 10.1007/Bf01285553 |
0.307 |
|
| 1997 |
Tedeschi G, Litvan I, Bonavita S, Bertolino A, Lundbom N, Patronas NJ, Hallett M. Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration. Brain : a Journal of Neurology. 120: 1541-52. PMID 9313638 DOI: 10.1093/Brain/120.9.1541 |
0.368 |
|
| 1997 |
Litvan I, Goetz CG, Jankovic J, Wenning GK, Booth V, Bartko JJ, McKee A, Jellinger K, Lai EC, Brandel JP, Verny M, Chaudhuri KR, Pearce RK, Agid Y. What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study. Archives of Neurology. 54: 937-44. PMID 9267967 DOI: 10.1001/Archneur.1997.00550200007003 |
0.336 |
|
| 1997 |
Litvan I. The clinical and pathologic hallmarks of progressive supranuclear palsy Current Opinion in Neurology. 10: 346-350. PMID 9266160 DOI: 10.1097/00019052-199708000-00011 |
0.383 |
|
| 1997 |
Litvan I, Agid Y, Sastry N, Jankovic J, Wenning GK, Goetz CG, Verny M, Brandel JP, Jellinger K, Chaudhuri KR, McKee A, Lai EC, Pearce RK, Bartko JJ, Sastrj N. What are the obstacles for an accurate clinical diagnosis of Pick's disease? A clinicopathologic study. Neurology. 49: 62-9. PMID 9222171 DOI: 10.1212/Wnl.49.1.62 |
0.414 |
|
| 1997 |
Litvan I, Sastry N, Sonies BC. Characterizing swallowing abnormalities in progressive supranuclear palsy Neurology. 48: 1654-1662. PMID 9191782 DOI: 10.1212/Wnl.48.6.1654 |
0.355 |
|
| 1997 |
Litvan I, Campbell G, Mangone CA, Verny M, McKee A, Chaudhuri KR, Jellinger K, Pearce RKB, D'Olhaberriague L. Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study Brain. 120: 65-74. PMID 9055798 DOI: 10.1093/Brain/120.1.65 |
0.444 |
|
| 1997 |
Litvan I, Agid Y, Goetz C, Jankovic J, Wenning GK, Brandel JP, Lai EC, Verny M, Ray-Chaudhuri K, McKee A, Jellinger K, Pearce RKB, Bartko JJ. Accuracy of the clinical diagnosis of corticobasal degeneration: A clinicopathologic study Neurology. 48: 119-125. PMID 9008506 DOI: 10.1212/Wnl.48.1.119 |
0.39 |
|
| 1996 |
Verny M, Jellinger KA, Hauw JJ, Bancher C, Litvan I, Agid Y. Progressive supranuclear palsy: a clinicopathological study of 21 cases. Acta Neuropathologica. 91: 427-31. PMID 8928621 DOI: 10.1007/S004010050446 |
0.398 |
|
| 1996 |
Litvan I, Fitzgibbon EJ. Can tropicamide eye drop response differentiate patients with progressive supranuclear palsy and Alzheimer's disease from healthy control subjects? Neurology. 47: 1324-1326. PMID 8909451 DOI: 10.1212/Wnl.47.5.1324 |
0.359 |
|
| 1996 |
Litvan I, Mega MS, Cummings JL, Fairbanks L. Neuropsychiatric aspects of progressive supranuclear palsy. Neurology. 47: 1184-9. PMID 8909427 DOI: 10.1212/Wnl.47.5.1184 |
0.376 |
|
| 1996 |
Litvan I, Agid Y, Jankovic J, Goetz C, Brandel JP, Lai EC, Wenning G, D'Olhaberriague L, Verny M, Chaudhuri KR, McKee A, Jellinger K, Bartko JJ, Mangone CA, Pearce RKB. Accuracy of Clinical Criteria for the Diagnosis of Progressive Supranuclear Palsy (Steele-Richardson-Olszewski Syndrome) Neurology. 46: 922-930. PMID 8780065 DOI: 10.1212/Wnl.46.4.922 |
0.436 |
|
| 1996 |
Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology. 47: 1-9. PMID 8710059 DOI: 10.1212/Wnl.47.1.1 |
0.389 |
|
| 1996 |
Litvan I, DeLeo JM, Hauw JJ, Daniel SE, Jellinger K, McKee A, Dickson D, Horoupian DS, Lantos PL, Tabaton M. What can artificial neural networks teach us about neurodegenerative disorders with extrapyramidal features? Brain : a Journal of Neurology. 119: 831-9. PMID 8673495 DOI: 10.1093/Brain/119.3.831 |
0.306 |
|
| 1996 |
Litvan I, Mangone CA, McKee A, Verny M, Parsa A, Jellinger K, D'Olhaberriague L, Chaudhuri KR, Pearce RK. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. Journal of Neurology, Neurosurgery, and Psychiatry. 60: 615-620. PMID 8648326 DOI: 10.1136/Jnnp.60.6.615 |
0.394 |
|
| 1996 |
Litvan I, Hauw JJ, Bartko JJ, Lantos PL, Daniel SE, Horoupian DS, McKee A, Dickson D, Bancher C, Tabaton M, Jellinger K, Anderson DW. Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. Journal of Neuropathology and Experimental Neurology. 55: 97-105. PMID 8558176 DOI: 10.1097/00005072-199601000-00010 |
0.386 |
|
| 1996 |
Litvan I, Agid Y, Brandel JP, Goetz C, Jankovic J, Lai EC, Wenning G. 641 Accuracy of the clinical diagnosis of pick's disease Neurobiology of Aging. 17. DOI: 10.1016/S0197-4580(96)80643-9 |
0.368 |
|
| 1995 |
Grafman J, Litvan I, Stark M. Neuropsychological features of progressive supranuclear palsy. Brain and Cognition. 28: 311-20. PMID 8546857 DOI: 10.1006/Brcg.1995.1260 |
0.344 |
|
| 1995 |
Litvan I, Sirigu A, Toothman J, Grafman J. What can preservation of autobiographic memory after muscarinic blockade tell us about the scopolamine model of dementia? Neurology. 45: 387-9. PMID 7854546 DOI: 10.1212/Wnl.45.2.387 |
0.327 |
|
| 1994 |
Litvan I, Blesa R, Clark K, Nichelli P, Atack JR, Mouradian MM, Grafman J, Chase TN. Pharmacological evaluation of the cholinergic system in progressive supranuclear palsy. Annals of Neurology. 36: 55-61. PMID 8024262 DOI: 10.1002/Ana.410360112 |
0.347 |
|
| 1994 |
Hauw JJ, Daniel SE, Dickson D, Horoupian DS, Jellinger K, Lantos PL, McKee A, Tabaton M, Litvan I. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology. 44: 2015-9. PMID 7969952 DOI: 10.1212/Wnl.44.11.2015 |
0.37 |
|
| 1994 |
Litvan I. Cognitive disturbances in progressive supranuclear palsy. Journal of Neural Transmission-Supplement. 42: 69-78. PMID 7964698 DOI: 10.1007/978-3-7091-6641-3_6 |
0.375 |
|
| 1994 |
Litvan I. Cholinergic approaches to the treatment of progressive supranuclear palsy Journal of Neural Transmission-Supplement. 42: 275-281. PMID 7964692 DOI: 10.1007/978-3-7091-6641-3_21 |
0.305 |
|
| 1992 |
Grafman J, Litvan I, Massaquoi S, Stewart M, Sirigu A, Hallett M. Cognitive planning deficit in patients with cerebellar atrophy. Neurology. 42: 1493-6. PMID 1641142 DOI: 10.1212/Wnl.42.8.1493 |
0.314 |
|
| 1991 |
Litvan I, Mohr E, Williams J, Gomez C, Chase TN. Differential memory and executive functions in demented patients with Parkinson's and Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 54: 25-9. PMID 2010755 DOI: 10.1136/Jnnp.54.1.25 |
0.419 |
|
| 1990 |
Mohr E, Juncos J, Cox C, Litvan I, Fedio P, Chase TN. Selective deficits in cognition and memory in high-functioning parkinsonian patients. Journal of Neurology, Neurosurgery, and Psychiatry. 53: 603-6. PMID 2391526 DOI: 10.1136/Jnnp.53.7.603 |
0.371 |
|
| 1990 |
Mohr E, Litvan I, Williams J, Fedio P, Chase TN. Selective deficits in Alzheimer and parkinsonian dementia: visuospatial function. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 17: 292-7. PMID 2207883 DOI: 10.1017/S0317167100030596 |
0.442 |
|
| 1989 |
Litvan I, Gomez C, Atack JR, Gillespie M, Kask AM, Mouradian MM, Chase TN. Physostigmine treatment of progressive supranuclear palsy. Annals of Neurology. 26: 404-7. PMID 2802540 DOI: 10.1002/Ana.410260318 |
0.316 |
|
| 1988 |
Junqué C, Roig C, Litvan I. Unilateral left cerebral deterioration documented by CT, MRI, and neuropsychological studies: A possible case of pick's disease Developmental Neuropsychology. 4: 295-302. DOI: 10.1080/87565648809540413 |
0.345 |
|
| Show low-probability matches. |